Generics

FDA Policy Seeks to Increase Number of Generics on Market

FDA Policy Seeks to Increase Number of Generics on Market

By

The FDA has announced a new policy to expedite reviews of generic drug applications in cases where competition is limited.

Concern Regarding Legislation Allowing Substitution of Biosimilars for Branded Drugs

Concern Regarding Legislation Allowing Substitution of Biosimilars for Branded Drugs

Much concern has been voiced regarding legislation allowing the substitution of biosimilars for branded drugs.

Sign Up for Free e-Newsletters